pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Asieris Pharmaceuticals (USA) Inc

updated 2mo ago
community read0 votes
pipeline
5
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(5)

pipeline depth5 products
Preclinical: 1Phase 1: 1Phase 2: 2Marketed: 1
1Preclinical1Phase 12Phase 21Marketed
Marketed
hexaminolevulinate hydrochloride
Cervical Intraepithelial Neoplasia (CIN)
Phase 2
APL-2302
Breast Cancer
Phase 2
nitroxoline
Muscle Invasive Bladder Cancer (MIBC)
Phase 1
nepicastat hydrochloride
Ulcerative Colitis
Preclinical
APL-1501
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Asieris Pharmaceuticals (USA) Inc jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Oncology3Breast Cancer1IBD (Crohn's + UC)1Prostate Cancer1Women's Health1
mentioned in
0news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?